13.06.2016 • NewsDede WillamsGMmaize

European Parliament Opposes GM-resistant Carnation

(c) Hadrian/Shutterstock
(c) Hadrian/Shutterstock

In two non-binding resolutions, the European Parliament has called on the European Commission (EC) to withdraw its authorizations for herbicide-resistant GM carnations and maize. Allowing GM carnations to be planted in the EU would encourage the worldwide use of a diabetes medicine as a herbicide, the EP said, adding that GM maize is resistant to the herbicide ingredient glyphosate.

In a vote of 430 to 188, with 33 abstentions, the plenary session objected to an EC decision to authorize the import, distribution and retailing in the EU of cut flowers of the genetically modified (GM) carnation SHD-27531-4, which is resistant to sulfonylurea herbicide.                                    

As the MEPs noted, sulfonylureas, a common second-line option for managing type 2 diabetes, are also used as herbicides, as they are highly toxic to plants at very low doses. Even if intended only for ornamental uses, creating a market for sulfonylurea-resistant plants could encourage the worldwide use of this medicine a herbicide with "worldwide detrimental effects on biodiversity and chemical contamination of drinking water,” they said.

On the question of authorizing the GM maize varieties made by Monsanto, the EP voted 426 to 202 with 33 abstentions against the EC’s proposal to allow the sale of products containing, consisting of or produced from genetically modified maize Bt11 × MIR162 × MIR604 × GA21 and genetically modified maizes combining two or three of the events Bt11, MIR162, MIR604 and GA21.

While some of these GM events confer tolerance to certain pests, the Parliament said the maize is resistant to glyphosate, the active ingredient in Monsanto’s Roundup program seen by some, in particular the World Health Organization’s IARC arm, as a “probable carcinogen.”

Since the current GM authorization process came into force, every GM approval has been granted by the Commission “without the support of a qualified majority of EU member state,” the MEPs said.

As a decision on whether or how long to renew glyphosate’s EU registration has still not been made by representatives of the member states, the Commission may soon be put in the position of having to decide on this, too. The current authorization expires on Jun. 30.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.